{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:03:38Z","timestamp":1793325818513,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Pharmaceuticals","doi-asserted-by":"publisher","award":["PA-SP\/PRJ-2020-9136"],"award-info":[{"award-number":["PA-SP\/PRJ-2020-9136"]}],"id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016238","name":"Ministerie van Economische Zaken en Klimaat","doi-asserted-by":"publisher","award":["2014\/077"],"award-info":[{"award-number":["2014\/077"]}],"id":[{"id":"10.13039\/501100016238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013955","name":"Astellas Pharma BV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jchromb.2023.123709","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T20:21:40Z","timestamp":1680898900000},"page":"123709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Expeditious quantification of plasma tacrolimus with liquid chromatography tandem mass spectrometry in solid organ transplantation"],"prefix":"10.1016","volume":"1222","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6073-6376","authenticated-orcid":false,"given":"Tanja R","family":"Zijp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J","family":"Knobbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"van Hateren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Roggeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4240-7506","authenticated-orcid":false,"given":"Hans","family":"Blokzijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Tji Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan JL","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4786-8961","authenticated-orcid":false,"given":"Erwin M","family":"Jongedijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TransplantLines","family":"Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1429-4789","authenticated-orcid":false,"given":"Daan J","family":"Touw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2023.123709_b0005","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jchromb.2023.123709_b0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2023.123709_b0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00003495-200059020-00021","article-title":"Tacrolimus A further update of its pharmacology and therapeutic use in the management of organ transplantation","volume":"59","author":"Plosker","year":"2000","journal-title":"Drugs."},{"key":"10.1016\/j.jchromb.2023.123709_b0020","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0090-9556(25)08219-4","article-title":"Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone","volume":"21","author":"Iwasaki","year":"1993","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2023.123709_b0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00007691-199406000-00009","article-title":"Comparison of different assays for the quantitation of FK 506 levels in blood or plasma","volume":"16","author":"Winkler","year":"1994","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2023.123709_b0030","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/ajt.12191","article-title":"Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials\u2020","volume":"13","author":"Bouamar","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jchromb.2023.123709_b0035","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/00007890-199610150-00009","article-title":"Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation","volume":"62","author":"Kershner","year":"1996","journal-title":"Transplantation."},{"key":"10.1016\/j.jchromb.2023.123709_b0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2125.1999.00007.x","article-title":"Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients","volume":"48","author":"B\u00f6ttiger","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2023.123709_b0045","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40262-019-00854-1","article-title":"Unbound plasma, total plasma, and whole-blood tacrolimus pharmacokinetics early after thoracic organ transplantation","volume":"59","author":"Sikma","year":"2020","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jchromb.2023.123709_b0050","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1111\/ajt.13309","article-title":"Pharmacokinetics and toxicity of tacrolimus early after heart and lung transplantation","volume":"15","author":"Sikma","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jchromb.2023.123709_b0055","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/000456329803500201","article-title":"Therapeutic monitoring of tacrolimus","volume":"35","author":"Trull","year":"1998","journal-title":"Pers. View Ann Clin Biochem."},{"key":"10.1016\/j.jchromb.2023.123709_b0060","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.clinbiochem.2013.02.011","article-title":"Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients","volume":"46","author":"Lemaitre","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jchromb.2023.123709_b0065","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/FTD.0000000000000780","article-title":"Measuring intracellular concentrations of calcineurin inhibitors: expert consensus from the international association of therapeutic drug monitoring and clinical toxicology expert panel","volume":"42","author":"Lemaitre","year":"2020","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2023.123709_b0070","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/bcp.14585","article-title":"Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients","volume":"87","author":"Francke","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2023.123709_b0075","article-title":"Monitoring the intracellular tacrolimus concentration in kidney transplant recipients with stable graft function","volume":"11","author":"Han","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.jchromb.2023.123709_b0080","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/pgs.10.43","article-title":"CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation","volume":"11","author":"Capron","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jchromb.2023.123709_b0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1432-2277.2011.01365.x","article-title":"Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study","volume":"25","author":"Capron","year":"2012","journal-title":"Transpl. Int."},{"key":"10.1016\/j.jchromb.2023.123709_b0090","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/FTD.0b013e318192304c","article-title":"Robust, high-throughput LC-MS\/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood","volume":"31","author":"Koster","year":"2009","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2023.123709_b0095","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Bioanalytical method validation guidance for industry, U.S. Dep. Heal. Hum. Serv. Food Drug Adm. (2018) 1\u201341."},{"key":"10.1016\/j.jchromb.2023.123709_b0100","first-page":"1","author":"European Medicines Agency","year":"2011","journal-title":"Guideline on bioanalytical method validation"},{"key":"10.1016\/j.jchromb.2023.123709_b0105","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.4155\/bio.14.198","article-title":"Some unnecessary or inadequate common practices in regulated LC-MS bioanalysis","volume":"6","author":"Tan","year":"2014","journal-title":"Bioanalysis."},{"key":"10.1016\/j.jchromb.2023.123709_b0110","doi-asserted-by":"crossref","first-page":"e024502","DOI":"10.1136\/bmjopen-2018-024502","article-title":"Rationale and design of TransplantLines: a prospective cohort study and biobank of solid organ transplant recipients","volume":"8","author":"Eisenga","year":"2018","journal-title":"BMJ Open."},{"key":"10.1016\/j.jchromb.2023.123709_b0115","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/FTD.0000000000000351","article-title":"Development of a simple and rapid method to measure the free fraction of tacrolimus in plasma using ultrafiltration and LC-MS\/MS","volume":"38","author":"Stienstra","year":"2016","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2023.123709_b0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.chroma.2018.03.010","article-title":"A simple and highly sensitive on-line column extraction liquid chromatography-tandem mass spectrometry method for the determination of protein-unbound tacrolimus in human plasma samples","volume":"1547","author":"Bittersohl","year":"2018","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jchromb.2023.123709_b0125","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3390\/pharmaceutics14030632","article-title":"Development and validation of the new liquid chromatography-tandem mass spectrometry method for the determination of unbound tacrolimus in the plasma ultrafiltrate of transplant recipients","volume":"14","author":"Bodnar-Broniarczyk","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jchromb.2023.123709_b0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.2042-7158.1994.tb03752.x","article-title":"Distribution and Protein Binding of FK506, a Potent Immunosuppressive Macrolide Lactone, in Human Blood and Its Uptake by Erythrocytes","volume":"46","author":"Nagase","year":"1994","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jchromb.2023.123709_b0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1056-8719(02)00158-2","article-title":"Validation of methods to study the distribution and protein binding of tacrolimus in human blood","volume":"46","author":"Zahir","year":"2001","journal-title":"J. Pharmacol. Toxicol. Methods."},{"key":"10.1016\/j.jchromb.2023.123709_b0140","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/clinchem\/39.6.1045","article-title":"Improvement and assessment of enzyme-linked immunosorbent assay to detect low FK506 concentrations in plasma or whole blood within 6 hours","volume":"39","author":"Wallemacq","year":"1993","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2023.123709_b0145","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, M10 BIOANALYTICAL METHOD VALIDATION AND STUDY SAMPLE ANALYSIS Guidance for Industry, (2022) 10\u201312. https:\/\/www.fda.gov\/media\/162903\/download."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223001198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223001198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:19:12Z","timestamp":1778822352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023223001198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":29,"alternative-id":["S1570023223001198"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123709","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expeditious quantification of plasma tacrolimus with liquid chromatography tandem mass spectrometry in solid organ transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123709"}}